Semrush Holdings, Inc. (SEMR)

Theseus Pharmaceuticals Stock Forecast

Stock Price Forecast

The 8 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $14.88, which forecasts a 98.93% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $21.

Price Target: $14.88 (+98.93%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$9.00	$14.88	$17	$21
Change	+20.32%	+98.93%	+127.27%	+180.75%

Analyst Ratings

The average analyst rating for Theseus Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	2	2	2	2	2	2
Buy	4	4	5	5	5	4
Hold	1	1	1	1	1	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Christopher Merwin Goldman Sachs	Goldman Sachs	Hold Maintains $12 → $9	Hold	Maintains	$12 → $9	+20.32%	Aug 6, 2025
Elizabeth Porter Morgan Stanley	Morgan Stanley	Buy → Hold Downgrades $13 → $9	Buy → Hold	Downgrades	$13 → $9	+20.32%	Aug 6, 2025
Scott Berg Needham	Needham	Strong Buy Maintains $18 → $12	Strong Buy	Maintains	$18 → $12	+60.43%	Aug 5, 2025
Jackson Ader Keybanc	Keybanc	Buy Maintains $16 → $12	Buy	Maintains	$16 → $12	+60.43%	Aug 5, 2025
Jackson Ader Keybanc	Keybanc	Buy Maintains $18 → $16	Buy	Maintains	$18 → $16	+113.90%	May 8, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

459.15M

Increased by 21.85%

from 376.82M

Revenue Next Year

544.10M

Increased by 18.50%

from 459.15M

EPS This Year

0.36

Increased by 529.26%

from 0.06

EPS Next Year

0.47

Increased by 33.49%

from 0.36

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	124.88M	188.00M	254.32M	307.68M	376.82M	459.15M	544.10M	643.51M
Revenue Growth	35.57%	50.55%	35.27%	20.98%	22.47%	21.85%	18.50%	18.27%
EPS	-0.07	-0.03	-0.24	0.01	0.06	0.36	0.47	0.65
EPS Growth	-	-	-	-	747.54%	529.26%	33.49%	36.02%
Forward PE	-	-	-	-	-	21.05	15.77	11.59
No. Analysts	-	-	-	-	-	8	8	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028
High	473.7M	569.9M	688.0M
Avg	459.2M	544.1M	643.5M
Low	439.2M	517.8M	609.8M

Revenue Growth

Revenue Growth	2025	2026	2027	2028
High	25.7%	24.1%	26.4%
Avg	21.9%	18.5%	18.3%
Low	16.6%	12.8%	12.1%

EPS Forecast

EPS	2025	2026	2027	2028
High	0.38	0.51	0.74
Avg	0.36	0.47	0.65
Low	0.31	0.41	0.57

EPS Growth

EPS Growth	2025	2026	2027	2028
High	569.5%	44.8%	55.0%
Avg	529.3%	33.5%	36.0%
Low	455.4%	15.8%	19.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.